| Literature DB >> 25486673 |
David P Vroege1, Carolien A Wijsman, Karen Broekhuizen, Anton J M de Craen, Diana van Heemst, Frans J G van der Ouderaa, Willem van Mechelen, P Eline Slagboom, Michael Catt, Rudi G J Westendorp, Evert A L M Verhagen, Simon P Mooijaart.
Abstract
BACKGROUND: Low physical activity is a major risk factor for several age-related diseases. Recently, we showed in a randomized controlled trial that a 12-week Web-based intervention (Philips DirectLife) to increase physical activity was effective in increasing physical activity levels and metabolic health in an inactive population aged 60-70 years.Entities:
Keywords: Internet; aging; metabolism; physical activity
Mesh:
Year: 2014 PMID: 25486673 PMCID: PMC4275504 DOI: 10.2196/jmir.3643
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Screenshot of DirectLife intervention program and accelerometer.
Baseline characteristic of control group, total intervention group, and successful participants.a
| Characteristics | Control group | Intervention group | ||||
|
| Control group (n=116) | Intervention group (n=119) |
| Successful participants (n=50) |
| |
|
|
|
|
|
|
| |
|
| Sex (female), n (%) | 49 (42.2) | 47 (39.5) | .67 | 13 (26) | .047 |
|
| Age (years), mean (SD) | 64.9 (2.8) | 64.7 (3.0) | .61 | 64.6 (2.8) | .63 |
|
|
|
|
|
|
| |
|
| Height (cm) | 172.1 (9.3) | 173.6 (9.9) | .25 | 175.7 (9.6) | .02 |
|
| Weight (kg) | 86.3 (15.8) | 87.4 (15.8) | .61 | 87.6 (15.6) | .64 |
|
| BMI (kg/m2) | 29.1 (4.7) | 28.9 (4.7) | .84 | 28.2 (3.7) | .25 |
|
| Waist circumference (cm) | 101.4 (12.3) | 102.3 (13.1) | .56 | 102.1 (12.2) | .74 |
|
| Fat percentage (%) | 36.4 (8.1) | 36.5 (7.6) | .95 | 34.5 (6.3) | .11 |
|
|
|
|
|
|
| |
|
| Framingham 10-year CVD risk (%), mean (SD) | 11.3 (7.5) | 11.9 (7.2) | .50 | 13.3 (7.5) | .10 |
|
|
|
|
|
|
| |
|
| 5-day moderate-to-vigorous activity (min/day), median (IQR) | 14.5 (8.2-32.5) | 16.8 (7.8-26.4) | .43 | 20.0 (9.2-27.5) | .97 |
|
|
|
|
|
|
| |
|
| Fasting venous glucose, mean (SD) | 5.7 (0.8) | 5.7 (0.7) | .94 | 5.6 (0.6) | .78 |
|
| Fasting insulin (mU/L), median (IQR) | 10.8 (7.0-15.8) | 11.5 (8.1-16.9) | .47 | 12.4 (8.0-19.8) | .32 |
|
| HbA1c (%), mean (SD) | 5.4 (0.3) | 5.4 (0.3) | .44 | 5.4 (0.2) | .72 |
|
| HOMA index, median (IQR) | 2.6 (1.7-4.3) | 2.8 (2.0-4.3) | .48 | 3.0 (2.0-5.0) | .39 |
|
| Total cholesterol, mean (SD) | 5.8 (1.0) | 5.7 (1.1) | .74 | 5.6 (1.1) | .28 |
|
| HDL cholesterol, mean (SD) | 1.4 (0.4) | 1.5 (0.5) | .51 | 1.4 (0.5) | .93 |
|
| Triglycerides, median (IQR) | 1.4 (1.1-2.0) | 1.5 (1.1-2.0) | .65 | 1.5 (1.1-2.0) | .99 |
|
| LDL cholesterol, mean (SD) | 3.6 (0.9) | 3.6 (1.0) | .66 | 3.4 (1.0) | .25 |
|
| Total/HDL cholesterol ratio, mean (SD) | 4.3 (1.3) | 4.2 (1.3) | .65 | 4.2 (1.3) | .70 |
|
| C-reactive protein, median (IQR) | 1.4 (0.8-4.1) | 1.6 (0.8-3.1) | .83 | 1.7 (0.7-3.8) | .85 |
a Data are presented as medians with interquartile range (IQR) when skewed. P values were calculated with t test (continuous data), Mann-Whitney (skewed data), or chi-square (categorical data).
Results for clinical parameters and glucose metabolism of successful participants compared to the total control group.a
| Characteristics | Control group (n=112) | Total intervention group (n=114) | Successful participants (n=50) | Relative increased | |||
|
| Mean Δ (SE) | Mean Δ (SE) |
| Mean Δ (SE) |
|
| |
|
|
|
|
|
|
|
| |
|
| Weight (kg) | –0.82 (0.21) | –1.49 (0.26) | .05 | –2.74 (0.40) | <.001 | 1.84 |
|
| BMI (kg/m2) | –0.29 (0.07) | –0.50 (0.09) | .07 | –0.91 (0.13) | <.001 | 1.82 |
|
| Waist circumference (cm) | –1.29 (0.34) | –2.33 (0.36) | .04 | –3.74 (0.55) | <.001 | 1.62 |
|
| Body fat (%) | –0.03 (0.24) | –0.88 (0.28) | .03 | –1.33 (0.34) | .001 | 1.51 |
|
|
|
|
|
|
|
| |
|
| Framingham risk score (%) | –0.01 (0.31) | –0.54 (0.33) | .25 | –0.90 (0.46) | .13 | 1.67 |
|
|
|
|
|
|
|
| |
|
| 5-day moderate-to-vigorous activity (min/day) | –0.15 (1.5) | 11.1 (2.1) | <.001 | 18.8 (3.86) | <.001 | 1.69 |
|
|
|
|
|
|
|
| |
|
| Fasting venous glucose (mmol/L) | –0.13 (0.04) | –0.20 (0.05) | .32 | –0.14 (0.06) | .77 | 0.70 |
|
| Lne insulin (mU/L) | –0.04 (0.04) | –0.16 (0.04) | .04 | –0.20 (0.06) | .03 | 1.25 |
|
| HbA1c (%) | –0.01 (0.01) | –0.05 (0.01) | .048 | –0.05 (0.02) | .07 | 1.00 |
|
| Ln HOMA index | –0.06 (0.04) | –0.20 (0.05) | .04 | –0.23 (0.06) | .05 | 1.15 |
|
| Total cholesterol (mmol/L) | –0.18 (0.05) | –0.25 (0.06) | .42 | –0.38 (0.09) | .08 | 1.52 |
|
| HDL cholesterol (mmol/L) | –0.04 (0.02) | –0.008 (0.02) | .29 | 0.03 (0.03) | .07 | N/A |
|
| Lne triglycerides (mmol/L) | –0.06 (0.02) | –0.10 (0.03) | .35 | –0.18 (0.04) | .02 | 1.80 |
|
| LDL cholesterol (mmol/L) | –0.11 (0.04) | –0.17 (0.04) | .43 | –0.28 (0.07) | .08 | 1.65 |
|
| Cholesterol/HDL ratio | –0.05 (0.05) | –0.20 (0.07) | .12 | –0.39 (0.11) | .007 | 1.95 |
|
| Lne C-reactive protein (mg/L) | –0.11 (0.09) | –0.12 (0.08) | .93 | –0.24 (0.15) | .50 | 2.00 |
a P values between groups were calculated with linear regression. All P values were adjusted for age and sex.
b P value for total control group vs total intervention group.
c P value for total control group vs successful participants.
d Relative increase of successful participants compared to total intervention group.
e Ln=natural logarithm. Natural logarithm presented when data at baseline skewed.
Figure 2Effect of the intervention on selected parameters in the different study groups.
Dose-response relationship of Δ minutes spent in moderate-to-vigorous physical activity with endpoints.a
| Characteristics | Intervention group |
| |||
|
| Low (n=36) | Middle (n=36) | High (n=36) |
| |
|
|
|
|
|
| |
|
| Mean (SD) | 22.5 (17.9) | 17.3 (16.5) | 19.0 (14.9) | .38 |
|
| Range | 2.4 to 87.2 | 0.8 to 92.0 | 2.4 to 62.4 |
|
|
|
|
|
|
| |
|
| Mean (SD) | –6.75 (8.20) | 5.91 (3.56) | 34.27 (21.52) |
|
|
| Range | –25.8 to 1.60 | 1.70 to 14.2 | 15.8 to 117.6 |
|
| Successful participants, n | 11 | 12 | 26 | .001 | |
|
|
|
|
|
| |
|
| Weight (kg) | –0.93 (0.35) | –0.64 (0.44) | –2.85 (0.51) | .004 |
|
| BMI (kg/m2) | –0.34 (0.12) | –0.23 (0.15) | –0.88 (0.17) | .02 |
|
| Waist circumference (cm) | –1.58 (0.52) | –1.92 (0.67) | –3.69 (0.72) | .03 |
|
| Fat percentage | –0.46 (0.48) | –0.44 (0.35) | –0.94 (0.43) | .43 |
|
|
|
|
|
| |
|
| Framingham risk score (%) | 0.43 (0.46) | –0.78 (0.52) | –1.28 (0.76) | .045 |
|
|
|
|
|
| |
|
| Glucose (mmol/L) | –0.23 (0.10) | –0.15 (0.09) | –0.21 (0.07) | .94 |
|
| Ln insulin (mU/L) | –0.14 (0.07) | –0.06 (0.08) | –0.26 (0.08) | .20 |
|
| HbA1c (%) | –0.04 (0.02) | –0.03 (0.02) | –0.07 (0.02) | .20 |
|
| Ln HOMA index | –0.18 (0.08) | –0.09 (0.08) | –0.30 (0.08) | .26 |
|
| Total cholesterol (mmol/L) | –0.29 (0.08) | –0.10 (0.10) | –0.40 (0.11) | .63 |
|
| HDL cholesterol (mmol/L) | –0.10 (0.04) | 0.01 (0.04) | 0.05 (0.03) | .007 |
|
| Ln triglycerides (mmol/L) | 0.003 (0.05) | –0.06 (0.05) | –0.22 (0.07) | .02 |
|
| LDL cholesterol (mmol/L) | –0.19 (0.06) | –0.09 (0.08) | –0.27 (0.09) | .61 |
|
| Cholesterol/HDL ratio | 0.006 (0.08) | –0.15 (0.11) | –0.48 (0.17) | .02 |
|
| Ln C-reactive protein (mg/L) | –0.11 (0.10) | –0.17 (0.13) | –0.23 (0.17) | .66 |
a P for trend was calculated with linear regression. P for trend was adjusted for sex and age, except for Framingham risk score for which age and sex are integrated.